bromocriptine has been researched along with Emesis in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (73.33) | 18.7374 |
1990's | 4 (26.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blomquist, L; Goiny, M; Posloncec, B; Uvnäs-Moberg, K | 1 |
Agid, Y; Illas, A; Lhermitte, F; Quinn, N | 1 |
Duchesne, C; Leke, R | 1 |
Akai, T; Hasan, S; Mizokawa, T; Nakada, Y; Nakagawa, H; Rettig, KJ; Wachtel, H; Yamaguchi, M | 1 |
Grünau, B; Hoppen, HO; Nolte, I | 1 |
Besser, GM; Grossman, AB; Jain, A; Jenkins, PJ; Jones, SL | 1 |
Endo, T; Hamaue, N; Kohno, Y; Minami, M; Nemoto, M | 1 |
Altwein, JE; Jacobi, GH | 1 |
Debono, A; Marsden, CD; Parkes, JD; Price, P; Rosenthaler, J | 1 |
Ward, HW | 1 |
Schneider, D | 1 |
Adashi, EY; Katz, E; Schran, HF | 1 |
Hashimoto, T; Koda, H; Kuriyama, K | 1 |
Janssens, LA | 1 |
Amoroso, S; Annunziato, L; Colace, G; Di Renzo, GF; Montemagno, U; Nappi, C; Taglialatela, M | 1 |
1 review(s) available for bromocriptine and Emesis
Article | Year |
---|---|
[Bromocriptine, a new therapeutic principle in prostatic adenoma and carcinoma. Basis, possibilities, limits].
Topics: Bromocriptine; Carcinoma; Humans; Male; Nausea; Prolactin; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Cell Surface; Testosterone; Vomiting | 1978 |
6 trial(s) available for bromocriptine and Emesis
Article | Year |
---|---|
Bromocriptine and domperidone in the treatment of Parkinson disease.
Topics: Benzimidazoles; Bromocriptine; Domperidone; Female; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Piperidines; Vomiting | 1981 |
[The treatment of pseudopregnancy in the bitch with prolactin inhibitors metergoline and bromocriptine].
Topics: Animals; Behavior, Animal; Bromocriptine; Dog Diseases; Dogs; Double-Blind Method; Estradiol; Female; Hormone Antagonists; Lactation; Metergoline; Progesterone; Prolactin; Pseudopregnancy; Vomiting | 1996 |
Oral prednisolone supplement abolishes the acute adverse effects following initiation of depot bromocriptine therapy.
Topics: Administration, Oral; Adult; Bromocriptine; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hyperprolactinemia; Hypotension; Male; Middle Aged; Nausea; Prednisolone; Vomiting | 1996 |
Plasma bromocriptine levels, clinical and growth hormone responses in Parkinsonism.
Topics: Aged; Blood Pressure; Bromocriptine; Clinical Trials as Topic; Female; Growth Hormone; Humans; Male; Metoclopramide; Middle Aged; Nausea; Parkinson Disease; Time Factors; Vomiting | 1978 |
Combined anti-prolactin and anti-oestrogen therapy for breast carcinoma.
Topics: Aged; Breast Neoplasms; Bromocriptine; Carbidopa; Drug Therapy, Combination; Estrogen Antagonists; Female; Humans; Levodopa; Middle Aged; Nausea; Prolactin; Remission, Spontaneous; Stilbenes; Tamoxifen; Time Factors; Vomiting | 1977 |
Domperidone antagonizes bromoergocriptine--induced nausea and vomiting without affecting its inhibition of prolactin secretion in puerperal women.
Topics: Adult; Bromocriptine; Domperidone; Drug Therapy, Combination; Female; Humans; Hyperprolactinemia; Nausea; Pregnancy; Puerperal Disorders; Vomiting | 1987 |
8 other study(ies) available for bromocriptine and Emesis
Article | Year |
---|---|
Increased levels of VIP (vasoactive intestinal polypeptide)-like immunoreactivity in peripheral venous blood of dogs following injections of apomorphine and bromocriptine. Do dopaminergic agents induce gastric relaxation and hypotension by a release of en
Topics: Animals; Apomorphine; Bromocriptine; Dogs; Gastrointestinal Hormones; Gastrointestinal Motility; Haloperidol; Hypotension; Muscle Relaxation; Receptors, Dopamine; Vasoactive Intestinal Peptide; Vomiting | 1982 |
Bromocriptine mesylate for prevention of postpartum lactation.
Topics: Adult; Breast; Bromocriptine; Dizziness; Female; Humans; Lactation; Nausea; Pregnancy; Time Factors; Vomiting | 1981 |
Terguride as a new anti-hyperprolactinemic agent: characterization in rats and dogs in comparison with bromocriptine.
Topics: Animals; Bromocriptine; Dogs; Dopamine Agents; Estradiol; Female; Glutathione; Hyperprolactinemia; Lactation; Lisuride; Luteinizing Hormone; Male; Motor Activity; Pituitary Neoplasms; Prolactinoma; Rats; Rats, Wistar; Receptors, Dopamine D2; Reserpine; Stereotyped Behavior; Vomiting | 1993 |
Effects of talipexole on emesis-related changes in abdominal afferent vagal activity and ileal serotonin metabolism in rats.
Topics: Abdomen; Animals; Azepines; Biogenic Monoamines; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Ileum; Male; Monoamine Oxidase; Rats; Rats, Wistar; Receptors, Dopamine D2; Serotonin; Tryptophan Hydroxylase; Vagus Nerve; Vomiting | 1997 |
[The "problem" of stopping loctation prevention and suppression with CB 154 (author's transl)].
Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Lactation; Nausea; Parity; Pregnancy; Vomiting; Weaning | 1976 |
Successful treatment of a prolactin-producing pituitary macroadenoma with intravaginal bromocriptine mesylate: a novel approach to intolerance of oral therapy.
Topics: Administration, Intravaginal; Adult; Bromocriptine; Female; Humans; Nausea; Pituitary Neoplasms; Prolactinoma; Vomiting | 1989 |
[Emetic and catalepsy-inducing actions of buflomedil].
Topics: Administration, Oral; Animals; Bromocriptine; Catalepsy; Dogs; Domperidone; Dose-Response Relationship, Drug; Levodopa; Male; Mice; Pyrrolidines; Vomiting | 1988 |
Treatment of pseudopregnancy with bromocriptin, an ergot alkaloid.
Topics: Animals; Bromocriptine; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Lactation; Metoclopramide; Nandrolone; Pregnancy; Pseudopregnancy; Vomiting | 1986 |